Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Griptha Putra Persada Tbk. (GRPH) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Griptha Putra Persada Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Griptha Putra Persada Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Griptha Putra Persada Tbk. trades at Rp63 (market cap 63B, 3.18M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 10.1× Griptha Putra Persada Tbk.'s market cap, and Griptha Putra Persada Tbk. is more actively traded (3.18M versus 843K). Which is the better fit depends on your goals.

GRPHLABS
Market Cap
63B635.95B
Volume
3.18M843K
Lot
31.8K8.43K
Turnover
200.21M137.6M
Average Price
62.97163.22
Value
200.21M137.6M
Indicative Equilibrium Price
63165
Indicative Equilibrium Volume
262246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GRPH
View details
LABS
View details

About Griptha Putra Persada Tbk.

PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.

Read more on GRPH

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS